Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiichiro Satake

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
JCI Insight|October 22, 2024
Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetesKatsuhito Ihara, Eiichiro Satake, Parker C Wilson, et al.
Science Translational Medicine|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetesZhuo Chen, Eiichiro Satake, Marcus G Pezzolesi, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2021
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (<i>HSD17B14</i>) with Reduced Progression to End Stage Kidney Disease in Type 1 DiabetesJosyf C Mychaleckyj, Erkka Valo, Takaharu Ichimura, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JCI Insight|October 22, 2024
Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetesKatsuhito Ihara, Eiichiro Satake, Parker C Wilson, et al.
Science Translational Medicine|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetesZhuo Chen, Eiichiro Satake, Marcus G Pezzolesi, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2021
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (<i>HSD17B14</i>) with Reduced Progression to End Stage Kidney Disease in Type 1 DiabetesJosyf C Mychaleckyj, Erkka Valo, Takaharu Ichimura, et al.
Pageof 3